Compare
BioCorRx Inc. vs Elite Health Systems Inc. vs Concentra Group Holdings Parent, Inc.
| Latest fiscal year | BioCorRx Inc. BICX | Elite Health Systems Inc. EHSI | Concentra Group Holdings Parent, Inc. CON |
|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $797.2K | $1.02M | $2.16B |
| Revenue growth (YoY) | n/m | n/a | +13.9% |
| Gross margin | n/a | 11.5% | n/a |
| Operating margin | -606.0% | -374.9% | 15.4% |
| Net margin | -431.5% | -762.1% | 7.7% |
| Net income | -$3.44M | -$7.80M | $166.41M |
| EPS (Diluted) | -$0.19 | n/a | $1.30 |
| Operating cash flow | -$2.30M | -$2.94M | $279.40M |
| Free cash flow | n/a | -$2.95M | $197.06M |
| Cash & equivalents | n/a | $3.76M | $79.90M |
| Total assets | $2.15M | $6.66M | $2.86B |
| Total liabilities | $13.67M | $1.35M | $2.44B |
| Shareholders' equity | -$11.22M | $5.31M | $401.02M |
| Return on year-end equity | n/a | -146.9% | 41.5% |
| Shares outstanding | 24.49M | 28.52M | 128.63M |
Revenue, most recent five fiscal years
| Fiscal year | BioCorRx Inc. | Elite Health Systems Inc. | Concentra Group Holdings Parent, Inc. |
|---|---|---|---|
| Latest | $797.2K Ended 2025-12-31 | $1.02M Ended 2025-12-31 | $2.16B Ended 2025-12-31 |
| 1 year earlier | $7.7K Ended 2024-12-31 | $0 Ended 2024-12-31 | $1.90B Ended 2024-12-31 |
| 2 years earlier | $89.2K Ended 2023-12-31 | $0 Ended 2023-12-31 | $1.84B Ended 2023-12-31 |
| 3 years earlier | $213.8K Ended 2022-12-31 | $0 Ended 2022-12-31 | $1.72B Ended 2022-12-31 |
| 4 years earlier | $48.3K Ended 2021-12-31 | $1.06M Ended 2021-12-31 | n/a |